Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement

Alessandra Vultaggio, Ioana Agache, Cezmi A. Akdis, Mubeccel Akdis, Sevim Bavbek, Apostolos Bossios, Jean Bousquet, Onur Boyman, Adam M. Chaker, Susan Chan, Alexia Chatzipetrou, Wojciech Feleszko, Davide Firinu, Marek Jutel, Paula Kauppi, Ludger Klimek, Antonios Kolios, Akash Kothari, Marek L. Kowalski, Andrea Matucci, Oscar Palomares, Oliver Pfaar, Barbara Rogala, Eva Untersmayr, Thomas Eiwegger

Open source

DOI: 10.1111/all.14407
Published: 2020-11
Container: Allergy
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/all.14407,
  title = {Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement},
  author = {Alessandra Vultaggio and Ioana Agache and Cezmi A. Akdis and Mubeccel Akdis and Sevim Bavbek and Apostolos Bossios and Jean Bousquet and Onur Boyman and Adam M. Chaker and Susan Chan and Alexia Chatzipetrou and Wojciech Feleszko and Davide Firinu and Marek Jutel and Paula Kauppi and Ludger Klimek and Antonios Kolios and Akash Kothari and Marek L. Kowalski and Andrea Matucci and Oscar Palomares and Oliver Pfaar and Barbara Rogala and Eva Untersmayr and Thomas Eiwegger},
  year = {2020},
  journal = {Allergy},
  doi = {10.1111/all.14407},
  url = {https://doi.org/10.1111/all.14407}
}

RIS

TY  - JOUR
TI  - Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement
AU  - Alessandra Vultaggio
AU  - Ioana Agache
AU  - Cezmi A. Akdis
AU  - Mubeccel Akdis
AU  - Sevim Bavbek
AU  - Apostolos Bossios
AU  - Jean Bousquet
AU  - Onur Boyman
AU  - Adam M. Chaker
AU  - Susan Chan
AU  - Alexia Chatzipetrou
AU  - Wojciech Feleszko
AU  - Davide Firinu
AU  - Marek Jutel
AU  - Paula Kauppi
AU  - Ludger Klimek
AU  - Antonios Kolios
AU  - Akash Kothari
AU  - Marek L. Kowalski
AU  - Andrea Matucci
AU  - Oscar Palomares
AU  - Oliver Pfaar
AU  - Barbara Rogala
AU  - Eva Untersmayr
AU  - Thomas Eiwegger
PY  - 2020
JO  - Allergy
DO  - 10.1111/all.14407
UR  - https://doi.org/10.1111/all.14407
ER  -

APA

Vultaggio, A., Agache, I., Akdis, C. A., Akdis, M., Bavbek, S., Bossios, A., Bousquet, J., Boyman, O., Chaker, A. M., Chan, S., Chatzipetrou, A., Feleszko, W., Firinu, D., Jutel, M., Kauppi, P., Klimek, L., Kolios, A., Kothari, A., Kowalski, M. L., Matucci, A., Palomares, O., Pfaar, O., Rogala, B., Untersmayr, E., & Eiwegger, T. (2020). Considerations on biologicals for patients with allergic disease in times of the COVID‐19 pandemic: An EAACI statement. Allergy. https://doi.org/10.1111/all.14407

Source records

crossref · retrieved 2026-09-25T15:05:19.165Z